KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Cash from Investing Activities (2016 - 2026)

Pacific Biosciences Of California has reported Cash from Investing Activities over the past 16 years, most recently at $26.0 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 55.31% year-over-year to $26.0 million; the TTM value through Dec 2025 reached $115.4 million, down 6.9%, while the annual FY2025 figure was $115.4 million, 6.9% down from the prior year.
  • Cash from Investing Activities for Q4 2025 was $26.0 million at Pacific Biosciences Of California, up from $18.9 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $242.3 million in Q3 2023 and troughed at -$460.8 million in Q2 2021.
  • A 5-year average of -$1.4 million and a median of $25.3 million in 2025 define the central range for Cash from Investing Activities.
  • Biggest five-year swings in Cash from Investing Activities: crashed 16017.8% in 2021 and later soared 414.72% in 2022.
  • Year by year, Cash from Investing Activities stood at $65.8 million in 2021, then rose by 22.28% to $80.4 million in 2022, then tumbled by 182.8% to -$66.6 million in 2023, then surged by 187.48% to $58.2 million in 2024, then plummeted by 55.31% to $26.0 million in 2025.
  • Business Quant data shows Cash from Investing Activities for PACB at $26.0 million in Q4 2025, $18.9 million in Q3 2025, and $25.3 million in Q2 2025.